Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug

Sanofi is licensing a RadioMedix radiopharmaceutical in development for neuroendocrine tumors. The French pharmaceutical giant is responsible for global commercialization of the therapy, a potential competitor to the Novartis radiopharmaceutical Lutathera. The post Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug appeared first on MedCity News.

Read More

Our Next Generations’ Health Depends on the Oral Health of Moms

This starts with viewing specialties such as oral health, maternal health, endocrinology, and cardiology — among others — as interconnected practices, not as separate areas. It also requires combining education, innovation, and investment to truly see — and feel — positive change and interconnected care The post Our Next Generations’ Health Depends on the Oral…

Read More

How Wooster Community Hospital collected $3.8M in patient balances with Collections Optimization Manager

Could a more targeted approach to patient collections help providers maximize revenue? Wooster Community Hospital (WCH) has proof that it can – to the tune of a 7.75% boost in annual collections. In a recent webinar, Kristen Shoup, Wooster’s Revenue Cycle Director, and Judy Wirtz, Senior Analytics Consultant at Experian Health, shared their success in…

Read More